About Allakos (ALLK)
Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more
- USD0.88
- USD0.92
- USD0.87
- USD5.64
- -26.70%
- --
- 207.65k
- 521.42k
- 61M
- 0.68
- -81.90%
Stock News
4 hours ago
1 Wall Street Analyst Thinks Tesla Stock Is Going to $258. Is It a Buy After a Post-Earnings Pullback?
Yahoo
6 hours ago
Warren Buffett Is in a Selling Mood. What’s Next?
Yahoo
6 hours ago
Weekly Market Outlook: Central Banks And U.S. Earnings. Will The BoJ Hike Rates?
SeekingAlpha
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
